Photocure ASA

Photocure ASA: Final grant of conditional share options

Oslo, Norway, 19 May 2021: Reference is made to the stock exchange release by

Photocure ASA ("Photocure" or the "Company") (OSE: PHO) published on 15

September 2021 regarding 370,000 share options granted conditionally.

The board of directors in Photocure ASA has today decided to convert a total of

370,000 conditional share options to unconditional share options.

Of the total share option conversion, the following unconditional share options

were converted for primary insiders:

· Dan Schneider, CEO, has received 60,000 share option, new total holding of

share options 210,000

· Erik Dahl, CFO, has received 35,000 share option, new total holding of share

options 65,000

· Geoffrey Coy, VP and General Manager of U.S. Operations, has received 35,000

share option, new total holding of share options 102,500

· Grete Hogstad, VP Global Strategic Marketing & Business Development, has

received 25,000 share option, new total holding of share options 43,750

· Kari Myren, VP Global Medical Affairs and Clinical Development, has received

25,000 share option, new total holding of share options 43,750

Primary insider notifications pursuant to the market abuse regulation article 19

are attached.

For further information, please contact:

Photocure

CFO Erik Dahl

Tel: +47 450 55 000

About Photocure ASA

Photocure: The Bladder Cancer Company delivers transformative solutions to

improve the lives of bladder cancer patients. Our unique technology, making

cancer cells glow bright pink, has led to better health outcomes for patients

worldwide. Photocure is headquartered in Oslo, Norway, and listed on the Oslo

Stock Exchange (OSE: PHO). For more information, please visit us at

www.photocure.com, www.hexvix.com or www.cysview.com

All trademarks mentioned in this release are protected by law and are registered

trademarks of Photocure ASA.

This information is subject to the disclosure requirements pursuant to the

market abuse regulation article 19 and 5-12 of the Norwegian Securities Trading

Act.

AI Terminal